Kobayashi Pharmaceutical Co., Ltd. (KBYPF)

Market Cap	3.29B +27.4%
Revenue (ttm)	1.03B +3.7%
Net Income	10.00M -86.2%
EPS	0.14 -86.2%
Shares Out	n/a
PE Ratio	285.39
Forward PE	n/a
Dividend	0.66 (1.68%)
Ex-Dividend Date	Dec 29, 2026

Volume	300
Open	40.76
Previous Close	34.05
Day's Range	39.47 - 40.76
52-Week Range	34.05 - 40.76
Beta	0.26
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 10, 2026

About Kobayashi Pharmaceutical

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sh...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1886
• Employees: 3,731
• Stock Exchange: OTCMKTS
• Ticker Symbol: KBYPF

Financial Performance

In 2025, Kobayashi Pharmaceutical's revenue was 165.74 billion, an increase of 0.09% compared to the previous year's 165.60 billion. Earnings were 3.66 billion, a decrease of -63.68%.

Financial numbers in JPY

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 9, 2026

Data Sources Report a data error